logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Aldrich N K Lau

This inventor holds 37 USPTO granted patents and 9 published patent applications and 4 EPO patents, primarily in Oligonucleotide Synthesis. Top assignees: Applied Biosystems, LLC, Hongene Biotech Corporation, Applera Corporation. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aldrich N K Lau. Retrieved from https://idiyas.com/inventor/aldrich-n-k-lau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 37 

% Patents Active = 75.7

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 216(Granted Patents)


Company Filing History:

goldMedal15 out of 532 
 
Applied Biosystems, LLC
 patents
silverMedal14 out of 19 
 
Hongene Biotech Corporation
 patents
bronzeMedal4 out of 496 
 
Applera Corporation
 patents
4. 2 out of 1,896 
 
Life Technologies Corporation
 patents
5. 1 out of 30 
 
Genapsys, Inc.
 patents
6. 1 out of 30,255 
 
Robert Bosch
 patents

Years Active: 2004-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Oligonucleotide Synthesis
Capillary Electrophoresis
Functionalized Compounds
Polymeric Solid Support
DNA Sequencing
Luminescence Standards
N-acetylgalactosamine
Fluid Processing Devices
High Speed Compositions
Biomolecular Interactions
Poly(N-vinylamide)
Analyte Detection
37 patents (USPTO):Explore Patents
1. 12180140 - Compounds and methods for liquid phase oligonucleotide synthesis (2024-12-31),
2. 12116382 - Functionalized N-acetylgalactosamine analogs (2024-10-15),
3. 12098371 - Lipid-pegylated compounds, preparations and uses thereof (2024-09-24),
4. 12092606 - Compositions and kits comprising interpenetrating polymer network for capillary electrophoresis (2024-09-17),
5. 12065516 - Polymeric solid support for oligonucleotide synthesis (2024-08-20),
6. 12065460 - Compositions and methods for liquid phase oligonucleotide synthesis (2024-08-20),
7. 11993626 - Functionalized N-acetylgalactosamine analogs (2024-05-28),
8. 11897914 - Synthesis of 2′ protected nucleosides (2024-02-13),
9. 11884691 - Functionalized n-acetylgalactosamine analogs (2024-01-30),
10. 11851454 - Compositions and methods for liquid phase oligonucleotide synthesis (2023-12-26),
11. 11814450 - Polymeric solid support for oligonucleotide synthesis (2023-11-14),
12. 11725073 - Compositions and methods for liquid phase oligonucleotide synthesis (2023-08-15),
13. 11692001 - Functionalized n-acetylgalactosamine analogs (2023-07-04),
14. 11649260 - Functionalized N-acetylgalactosamine nucleosides (2023-05-16),
15. 10683389 - Beads for nucleic acid sequencing (2020-06-16),

Title: Innovations and Contributions of Aldrich N K Lau in Oligonucleotide Synthesis

Introduction

Aldrich N K Lau is a prominent inventor based in Palo Alto, CA, with an impressive portfolio of 37 patents. His work primarily focuses on the development of compounds and methods that enhance liquid phase oligonucleotide synthesis, significantly contributing to advancements in biotechnology and therapeutic applications.

Latest Patents

Among his latest patents, Lau has developed innovative methods for liquid phase oligonucleotide synthesis. One notable patent describes the use of small molecules with lipophilic groups to improve this synthesis method. Additionally, he has made significant contributions with his patent on functionalized N-acetylgalactosamine analogs, which details methods of preparation and potential uses for targeted delivery in oligonucleotide-based therapeutics.

Career Highlights

Aldrich Lau has held pivotal roles in notable companies such as Applied Biosystems, LLC and Hongene Biotech Corporation. His expertise in oligonucleotide synthesis and functionalization has placed him at the forefront of research and innovation within the biotech sector. His contributions to both academic and industrial research have made profound impacts on the development of new therapeutic agents.

Collaborations

Throughout his career, Lau has collaborated with distinguished colleagues, including David Yu and Yun-Chiao Yao, to drive forward research initiatives that aim to improve oligonucleotide synthesis and application. These partnerships have facilitated the sharing of knowledge and technology, elevating the research output and enhancing the impact of their innovations.

Conclusion

Aldrich N K Lau's advancements in chemical compounds and synthesis techniques have made him a key figure in the field of biotechnology. His dedication to innovation and collaboration continues to inspire new developments in oligonucleotide-based therapeutics, marking his influence on future scientific discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…